EUR-Lex Access to European Union law
This document is an excerpt from the EUR-Lex website
Document C:2023:323:FULL
Official Journal of the European Union, C 323, 13 September 2023
Official Journal of the European Union, C 323, 13 September 2023
Official Journal of the European Union, C 323, 13 September 2023
ISSN 1977-091X |
||
Official Journal of the European Union |
C 323 |
|
English edition |
Information and Notices |
Volume 66 |
Contents |
page |
|
|
II Information |
|
|
INFORMATION FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES |
|
|
European Commission |
|
2023/C 323/01 |
Non-opposition to a notified concentration (Case M.10979 – PROVIDENCE EQUITY PARTNERS / ROTHSCHILD & CO / A2MAC1) ( 1 ) |
|
2023/C 323/02 |
Non-opposition to a notified concentration (Case M.11130 – SONAE / BKCF / BKSA / UNIVERSO IME / JV) ( 1 ) |
|
IV Notices |
|
|
NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES |
|
|
European Commission |
|
2023/C 323/03 |
||
|
Court of Auditors |
|
2023/C 323/04 |
||
|
NOTICES FROM MEMBER STATES |
|
2023/C 323/05 |
|
V Announcements |
|
|
PROCEDURES RELATING TO THE IMPLEMENTATION OF THE COMMON COMMERCIAL POLICY |
|
|
European Commission |
|
2023/C 323/06 |
||
|
PROCEDURES RELATING TO THE IMPLEMENTATION OF COMPETITION POLICY |
|
|
European Commission |
|
2023/C 323/07 |
Prior notification of a concentration (Case M.11267 – SMRP / DR SCHNEIDER GROUP) – Candidate case for simplified procedure ( 1 ) |
|
2023/C 323/08 |
Prior notification of a concentration (Case M.11192 – CDC / VAUBAN / CORIANCE) – Candidate case for simplified procedure ( 1 ) |
|
2023/C 323/09 |
Prior notification of a concentration (Case M.10966 – COCHLEAR / OTICON MEDICAL) ( 1 ) |
|
2023/C 323/10 |
Prior notification of a concentration (Case M.11191 – QIA / OIA / ASAAL INTERNATIONAL INVESTMENT) – Candidate case for simplified procedure ( 1 ) |
|
|
|
(1) Text with EEA relevance. |
EN |
|
II Information
INFORMATION FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES
European Commission
13.9.2023 |
EN |
Official Journal of the European Union |
C 323/1 |
Non-opposition to a notified concentration
(Case M.10979 – PROVIDENCE EQUITY PARTNERS / ROTHSCHILD & CO / A2MAC1)
(Text with EEA relevance)
(2023/C 323/01)
On 21 December 2022, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:
— |
in the merger section of the ‘Competition policy’ website of the Commission (https://competition-cases.ec.europa.eu/search). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
— |
in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32022M10979. EUR-Lex is the online point of access to European Union law. |
13.9.2023 |
EN |
Official Journal of the European Union |
C 323/2 |
Non-opposition to a notified concentration
(Case M.11130 – SONAE / BKCF / BKSA / UNIVERSO IME / JV)
(Text with EEA relevance)
(2023/C 323/02)
On 28 August 2023, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:
— |
in the merger section of the ‘Competition policy’ website of the Commission (https://competition-cases.ec.europa.eu/search). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
— |
in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32023M11130. EUR-Lex is the online point of access to European Union law. |
IV Notices
NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES
European Commission
13.9.2023 |
EN |
Official Journal of the European Union |
C 323/3 |
1 euro =
|
Currency |
Exchange rate |
USD |
US dollar |
1,0713 |
JPY |
Japanese yen |
157,42 |
DKK |
Danish krone |
7,4601 |
GBP |
Pound sterling |
0,85925 |
SEK |
Swedish krona |
11,8875 |
CHF |
Swiss franc |
0,9561 |
ISK |
Iceland króna |
143,70 |
NOK |
Norwegian krone |
11,4540 |
BGN |
Bulgarian lev |
1,9558 |
CZK |
Czech koruna |
24,605 |
HUF |
Hungarian forint |
385,08 |
PLN |
Polish zloty |
4,6600 |
RON |
Romanian leu |
4,9710 |
TRY |
Turkish lira |
28,8155 |
AUD |
Australian dollar |
1,6682 |
CAD |
Canadian dollar |
1,4550 |
HKD |
Hong Kong dollar |
8,3879 |
NZD |
New Zealand dollar |
1,8150 |
SGD |
Singapore dollar |
1,4597 |
KRW |
South Korean won |
1 422,62 |
ZAR |
South African rand |
20,3284 |
CNY |
Chinese yuan renminbi |
7,8115 |
IDR |
Indonesian rupiah |
16 462,67 |
MYR |
Malaysian ringgit |
5,0105 |
PHP |
Philippine peso |
60,689 |
RUB |
Russian rouble |
|
THB |
Thai baht |
38,229 |
BRL |
Brazilian real |
5,2920 |
MXN |
Mexican peso |
18,5691 |
INR |
Indian rupee |
88,8260 |
(1) Source: reference exchange rate published by the ECB.
Court of Auditors
13.9.2023 |
EN |
Official Journal of the European Union |
C 323/4 |
Special report 21/2023:
‘The Spotlight Initiative to end violence against women and girls – Ambitious but so far with limited impact’
(2023/C 323/04)
The European Court of Auditors has published its special report 21/2023: ‘The Spotlight Initiative to end violence against women and girls – Ambitious but so far with limited impact’.
The report can be consulted directly or downloaded at the European Court of Auditors’ website: https://www.eca.europa.eu/en/publications/sr-2023-21
NOTICES FROM MEMBER STATES
13.9.2023 |
EN |
Official Journal of the European Union |
C 323/5 |
List of central authorities nominated by the Member States to deal with the return of cultural objects unlawfully removed from a Member State and applying Article 4 of Directive 2014/60/EU
(2023/C 323/05)
Member State |
Central authority |
|||||||||||||||||
Belgium |
|
|||||||||||||||||
Bulgaria |
|
|||||||||||||||||
Czechia |
|
|||||||||||||||||
Denmark |
Tel. +45 91324566 Email: kulturvaerdier@kb.dk https://kulturvaerdier.kb.dk/ |
|||||||||||||||||
Germany |
Email: Divison: k53@bkm.bund.de www.kulturstaatsministerin.de |
|||||||||||||||||
Estonia |
Email: min@kul.ee |
|||||||||||||||||
Ireland |
Email: csu@tcagsm.gov.ie |
|||||||||||||||||
Spain |
Email: secretaria.bellasartes@cultura.gob.es Tel. +34 917017262 |
|||||||||||||||||
France |
https://www.culture.gouv.fr/ Email: communication.dgpat@culture.gouv.fr
Email: secretariat.ocbc@interieur.gouv.fr Email: sirasco-ocbc@interieur.gouv.fr Tel. +33 147449853 |
|||||||||||||||||
Croatia |
|
|||||||||||||||||
Italy |
Autorità Centrale: Segretario Generale Email: sg@cultura.gov.it Tel. +39 0667232002 – 2433 Ente di contatto
|
|||||||||||||||||
Cyprus |
Email: antiquitiesdep@da.culture.gov.cy Tel. +357 22865886/+357 22865801 |
|||||||||||||||||
Latvia |
|
|||||||||||||||||
Lithuania |
Tel. +370 67185970 |
|||||||||||||||||
Luxembourg |
|
|||||||||||||||||
Hungary |
Email: mutargy@ekm.gov.hu Tel. +36 17952510 |
|||||||||||||||||
Μalta |
Τel. +356 2395000 |
|||||||||||||||||
Netherlands |
www.inspectie-oe.nl |
|||||||||||||||||
Austria |
Email: recht@bda.gv.at Tel. +43 153415-850212 |
|||||||||||||||||
Poland |
|
|||||||||||||||||
Portugal |
Email: dgpc@dgpc.pt Tel. +351 213614200
Tel. +351 213596200 Fax +351 213523180 Email: cinemateca@cinemateca.pt
Email: secretariado@dglab.gov.pt Tel. +351 210037100 Fax +351 210037101
Email: paragao@bnportugal.gov.pt Tel. +351 217982000 |
|||||||||||||||||
Romania |
Email: comunicare@cultura.ro Tel. +40 240516072/+40 212228291 |
|||||||||||||||||
Slovenia |
|
|||||||||||||||||
Slovakia |
Email: skd@culture.gov.sk Tel. +421 220482414
|
|||||||||||||||||
Finland |
Email: registry.okm@gov.fi |
|||||||||||||||||
Sweden |
|
V Announcements
PROCEDURES RELATING TO THE IMPLEMENTATION OF THE COMMON COMMERCIAL POLICY
European Commission
13.9.2023 |
EN |
Official Journal of the European Union |
C 323/10 |
Notice amending the Notice of initiation of an anti-dumping proceeding concerning imports of certain manganese dioxides originating in the People’s Republic of China published on 16 February 2023
(2023/C 323/06)
On 16 February 2023, the European Commission (‘the Commission’) initiated an anti-dumping proceeding concerning imports of certain manganese dioxides (‘EMD’ or ‘the product under investigation’), originating in the People’s Republic of China (‘the PRC’ or ‘the country concerned’) (1) pursuant to Article 5 of Regulation (EU) 2016/1036 of the European Parliament and of the Council of 8 June 2016 on protection against dumped imports from countries not members of the European Union (2) (‘the basic Regulation’).
On 7 September 2023, AUTLAN EMD SL (‘the complainant’) made a request in accordance with Article 7(2a) of the basic Regulation to include the examination of alleged raw material distortions in the country concerned reagrding the product under investigation in the above-mentioned anti-dumping proceeding, to assess whether, if relevant, a duty lower than the margin of dumping would be sufficient to remove injury This request was made by the Union industry of certain manganese dioxides in the sense of Article 5(4) of the basic Regulation.
An open version of the request is available in the file for inspection by interested parties. Section 5.6 of the Notice of initiation of an anti-dumping proceeding concerning imports of certain manganese dioxides originating in the People’s Republic of China (3) (‘the original Notice of Initiation’) provides information about access to the file for interested parties.
The notice of the initiation published on 16 February 2023 is hereby amended pursuant to Article 7(2a) of the basic Regulation in order to examine the raw material distortions and to assess whether, if relevant, a duty lower than the margin of dumping would be sufficient to remove injury.
A new point 4.1. shall be inserted after point 4 of the Notice of initiation of 16 February 2023 and shall read as follows:
‘4.1. Allegation of raw material distortions
The complainant has provided sufficient evidence that there may be raw material distortions in the country concerned regarding the product under investigation. According to the evidence provided by the complainant, there are no value added tax (“VAT”) refunds on exports of manganese ore in the country concerned. VAT refund reduction or withdrawal are listed in Article 7(2a), 2nd subparagraph of the basic Regulation, as one of the relevant raw material distortions. The evidence provided also shows that manganese ore accounts for well over the threshold of 17 % of the cost of production of the product under investigation in the country concerned as required by Article 7(2a), 5nd subparagraph of the basic Regulation. The comparison of the price of manganese ore in the PRC with the undistorted price of manganese ore sold in representative international markets shows that Chinese prices are below those of representative international markets pursuant to Article 7(2a), 2nd subparagraph of the basic Regulation.
Therefore, in accordance with Article 7(2a) of the basic Regulation, the investigation will examine the alleged distortions to assess whether, if relevant, a duty lower than the margin of dumping would be sufficient to remove injury. Should other distortions covered by Article 7(2a) of the basic Regulation be identified in the course of the investigation, the investigation may also cover these distortions.’
The following paragraph should be added after the third paragraph of point 5 of the Notice of initiation of 16 February 2023:
‘In order to determine whether Article 7(2a) applies, the investigation will also examine the Union’s interest under Article 7(2b) of the basic Regulation.’.
A new point 5.5.1. shall be inserted after the first two paragraphs of point 5.5. of the Notice of initiation of 16 February 2023 and shall read as follows:
‘5.5.1. Procedure for the assessment of Union interest in case of allegations of raw material distortions
In cases of distortions on raw materials as identified in Article 7(2a) of the basic Regulation, the Commission will conduct a Union interest test as laid out in Article 7(2b) of that Regulation. If the Commission decides, when establishing the level of duties subject to Article 7 of that Regulation, to apply Article 7(2), it will carry out the Union interest test in accordance with Article 21 on the basis of the measures determined pursuant to Article 7(2).
Interested parties are invited to provide all pertinent information enabling the Commission to determine whether it is in the Union interest to set the level of the measures in accordance with Article 7(2a) of the basic Regulation. In particular, interested parties are invited to provide any information about spare capacities in the country concerned, competition for raw materials and the effect on supply chains for companies in the Union. In the absence of cooperation the Commission may conclude that it is in accordance with the Union interest to apply Article 7(2a) of the basic Regulation.
Should the Commission decide to apply Article 7(2) of the basic Regulation, a decision will be reached, pursuant to Article 21, as to whether the adoption of anti-dumping measures would not be against the Union interest. Union producers, importers and their representative associations, users and their representative associations, trade unions and representative consumer organisations are invited to provide the Commission with information on the Union interest. In order to participate in the investigation, representative consumer organisations have to demonstrate that there is an objective link between their activities and the product under investigation.
Information concerning the assessment of Union interest must be provided within 15 days of the date of publication of this Notice unless otherwise specified. This information may be provided either in a free format or by completing relevant parts of the questionnaires on raw material distortions prepared by the Commission. The information submitted will only be taken into account if supported by factual evidence at the time of submission. The questionnaires are available in the file for inspection by interested parties and on DG Trade’s website:
|
https://tron.trade.ec.europa.eu/investigations/case-view?caseId=2676’. |
(1) OJ C 57, 16.2.2023, p. 11.
PROCEDURES RELATING TO THE IMPLEMENTATION OF COMPETITION POLICY
European Commission
13.9.2023 |
EN |
Official Journal of the European Union |
C 323/12 |
Prior notification of a concentration
(Case M.11267 – SMRP / DR SCHNEIDER GROUP)
Candidate case for simplified procedure
(Text with EEA relevance)
(2023/C 323/07)
1.
On 31 August 2023, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1).This notification concerns the following undertakings:
— |
Samvardhana Motherson Automotive Systems Group B.V. (‘SMRP’, the Netherlands), belonging to Samvardhana Motherson International Limited (‘Motherson Group’, India), |
— |
Dr. Schneider Group’s (Germany) automotive business. |
SMRP will acquire within the meaning of Article 3(1)(b) of the Merger Regulation sole control of Dr. Schneider Group’s automotive business.
The concentration is accomplished by way of purchase of shares and assets.
2.
The business activities of the undertakings concerned are the following:
— |
Motherson Group is a global producer and supplier of automotive components, |
— |
Dr. Schneider Group’s automotive business supplies interior components and systems mainly used in passenger vehicles. |
3.
On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.
4.
The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:
M.11267 – SMRP / DR SCHNEIDER GROUP
Observations can be sent to the Commission by email or by post. Please use the contact details below:
Email: COMP-MERGER-REGISTRY@ec.europa.eu
Postal address:
European Commission |
Directorate-General for Competition |
Merger Registry |
1049 Bruxelles/Brussel |
BELGIQUE/BELGIË |
(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).
13.9.2023 |
EN |
Official Journal of the European Union |
C 323/14 |
Prior notification of a concentration
(Case M.11192 – CDC / VAUBAN / CORIANCE)
Candidate case for simplified procedure
(Text with EEA relevance)
(2023/C 323/08)
1.
On 31 August 2023, the Commission received notification of a proposed concentration pursuant to Article 4 and following a referral pursuant to Article 4(5) of Council Regulation (EC) No 139/2004 (1).This notification concerns the following undertakings:
— |
Vauban Infrastructure Partners (‘Vauban’, France), ultimately solely controlled by BPCE S.A. (‘BPCE’, France), |
— |
Caisse des Dépôts et Consignations (‘CDC’, France), |
— |
Coriance Holding (‘Coriance’, France). |
Vauban and CDC will acquire within the meaning of Article 3(1)(b) of the Merger Regulation joint control of the whole of Coriance.
The concentration is accomplished by way of purchase of shares.
2.
The business activities of the undertakings concerned are the following:
— |
Vauban is an asset management company specializing in private equity infrastructure investments that contribute to the sustainable development of local communities and their environment, |
— |
CDC is a French public institution with special legal status carrying out activities of public service and general interest as well as activities open to competition, |
— |
Coriance is mainly active in the district heating and cooling sectors in France and in Belgium. |
3.
On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.
4.
Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.
5.
The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:
M.11192 – VAUBAN / CDC / CORIANCE
Observations can be sent to the Commission by email or by post. Please use the contact details below:
Email: COMP-MERGER-REGISTRY@ec.europa.eu
Postal address:
European Commission |
Directorate-General for Competition |
Merger Registry |
1049 Bruxelles/Brussel |
BELGIQUE/BELGIË |
(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).
13.9.2023 |
EN |
Official Journal of the European Union |
C 323/16 |
Prior notification of a concentration
(Case M.10966 – COCHLEAR / OTICON MEDICAL)
(Text with EEA relevance)
(2023/C 323/09)
1.
On 4 September 2023, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1).This notification concerns the following undertakings:
— |
Cochlear Limited (‘Cochlear’, Australia), |
— |
The cochlear implant (‘CI’) business of Oticon Medical, the hearing implant division of Demant A/S, a Danish publicly listed company (Denmark). |
Cochlear will acquire within the meaning of Article 3(1)(b) of the Merger Regulation control of the whole of Oticon Medical’s CI business.
The concentration is accomplished by way of purchase of shares and assets.
The concentration has been referred to the Commission by the Spanish Competition Authority (Comisión Nacional de los Mercados y la Competencia) pursuant to Article 22(3) of the Merger Regulation. The referral was subsequently joined by Bulgaria, Denmark, Finland, France, Ireland, Italy, Lithuania, the Netherlands, Norway, Poland, Portugal and Sweden.
2.
The business activities of the undertakings concerned are the following:
— |
Cochlear, a company incorporated under the laws of New South Wales (Australia), is the ultimate parent company of the Cochlear Group which provides implantable hearing solutions around the globe, |
— |
Oticon Medical’s CI business develops, manufactures and sells globally cochlear implants. |
3.
On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.
4.
The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:
M.10966 – COCHLEAR / OTICON MEDICAL
Observations can be sent to the Commission by email or by post. Please use the contact details below:
Email: COMP-MERGER-REGISTRY@ec.europa.eu
Postal address:
European Commission |
Directorate-General for Competition |
Merger Registry |
1049 Bruxelles/Brussel |
BELGIQUE/BELGIË |
(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).
13.9.2023 |
EN |
Official Journal of the European Union |
C 323/17 |
Prior notification of a concentration
(Case M.11191 – QIA / OIA / ASAAL INTERNATIONAL INVESTMENT)
Candidate case for simplified procedure
(Text with EEA relevance)
(2023/C 323/10)
1.
On 6 September 2023, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1).This notification concerns the following undertakings:
— |
Qatar Investment Authority (‘QIA’, Qatar), |
— |
Oman Investment Authority (‘OIA’, Oman), |
— |
Aasaal International Investment SAOC (‘Target Entity’, Oman). |
QIA and OIA will acquire within the meaning of Article 3(1)(b) and 3(4) of the Merger Regulation joint control of the Target Entity.
The concentration is accomplished by way of purchase of shares.
2.
The business activities of the undertakings concerned are the following:
— |
QIA is the sovereign wealth fund of the State of Qatar. |
— |
OIA is the sovereign wealth fund of the Sultanate of Oman. |
— |
The Target Entity is a closed joint stock company established for the purposes of investing in, owning, establishing, overseeing, and managing hotels, resorts and motels exclusively in Oman. |
3.
On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.
4.
The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:
M.11191 – QIA / OIA / ASAAL INTERNATIONAL INVESTMENT
Observations can be sent to the Commission by email or by post. Please use the contact details below:
Email: COMP-MERGER-REGISTRY@ec.europa.eu
Postal address:
European Commission |
Directorate-General for Competition |
Merger Registry |
1049 Bruxelles/Brussel |
BELGIQUE/BELGIË |
(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).